Clinical trials: Vagus Nerve Dysfunction

Vascular Dementia, Mild Cognitive Impairment

Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment

• Active, not recruiting
• Age: 55 to 89 years
• Medical device

This clinical trial evaluates the preliminary effectiveness and safety of Cerogrin, a medical device developed by Neurogrin Inc.

Trial name

NCT07149038

Testing

Cerogrin

Where

South Korea

Volunteers

24 people

Sponsor

Neurogrin Inc.